WCN will bring together leading scientists, public health experts, policy-makers to translate recent momentous scientific advances into action that will address means to end the epidemic, within the current context of significant global economic challenges.
Co-hosted by the Japanese Society of Neurology and Asian and Oceanian Association of Neurology. This year's theme will be "Defining the Future of Neurology".
Abstract Submission Deadline: Thursday, 6 April 2017
(Bursaries are available)
Early Bird Registration Deadline: Wednesday, June 14, 2017
The Kyoto story is a tradition of innovation. Time here is packed with opportunities to rub shoulders with new frontier industries and top Japanese scholars.
Half of all Japanese Nobel Prize winners have been Kyoto researchers. Nobel Prize in Physiology or Medicine in 2012 was awarded to Prof. Shinya Yamanaka from Kyoto. His discovery of induced pluripotent stem (iPS) cells started a revolution in stem cell research not only in neurodegenerative disorders but also in other fields of medicine.
This tradition of innovation is also the life blood of Kyoto industry that has produced some of the world's most exciting companies such as Kyocera, Murata, Shimadzu, Omron. Much of the battery technology that makes today's electric vehicles a viable mobility choice is the brain child of Kyoto boffins.